Opinion
What investors can learn from analysing R&D spending
High levels of R&D do not necessarily translate into increased returns on invested capital.
Tony BoydContributorResearch and development is the secret sauce that flows through the veins of every great company whether it is involved in technology, manufacturing, retail, financial services, healthcare or mining.
For the purposes of this column, I want to focus on the R&D expenditure of four companies with strong Australian connections – Atlassian, Mesoblast, Seeing Machines and Xero. Apart from having high levels of R&D expenses relative to revenue, these companies are all losing money.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Technology
Fetching latest articles